User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Is there a prostate-specific antigen upper limit for radical prostatectomy?

Primary tabs

Gontero, Paulo Spahn, Martin Tombal, Bertrand [UCL] Bader, Pia Hsu, Chao-Yu Joniau, Steven

• To assess the feasibility of radical prostatectomy (RP) in a series of patients with prostate cancer with very high prostate-specific antigen (PSA) levels by comparing the clinical outcomes of different PSA thresholds (20.1-50 ng/mL, 50.1-100 ng/mL and >100 ng/mL, respectively).

Document type Article de périodique (Journal article) – Article de recherche – Comparative Study, Journal Article
Access type Accès restreint
Publication date 2011
Language Anglais
Journal information "BJU International" - Vol. 108, no. 7, p. 1093-1100 (2011)
Peer reviewed yes
Publisher Wiley-Blackwell Publishing Ltd.
issn 1464-4096
Publication status Publié
Affiliations UCL - (SLuc) Service d'urologie
UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
MESH Subject Aged ; Humans ; Male ; Prostate-Specific Antigen - blood ; Prostatectomy ; Prostatic Neoplasms - blood, mortality, surgery ; Retrospective Studies ; Survival Rate
Keywords Prostate cancer ; Radical prostatectomy ; Prostate-specific antigen
Links
  1. O'Brien Matthew Frank, Cronin Angel M., Fearn Paul A., Smith Brandon, Stasi Jason, Guillonneau Bertrand, Scardino Peter T., Eastham James A., Vickers Andrew J., Lilja Hans, Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy, 10.1200/jco.2008.19.9794
  2. Makarov Danil V., Trock Bruce J., Humphreys Elizabeth B., Mangold Leslie A., Walsh Patrick C., Epstein Jonathan I., Partin Alan W., Updated Nomogram to Predict Pathologic Stage of Prostate Cancer Given Prostate-Specific Antigen Level, Clinical Stage, and Biopsy Gleason Score (Partin Tables) Based on Cases from 2000 to 2005, 10.1016/j.urology.2007.03.042
  3. D’Amico Anthony V., Moul Judd, Carroll Peter R., Sun Leon, Lubeck Deborah, Chen Ming-Hui, Cancer-Specific Mortality After Surgery or Radiation for Patients With Clinically Localized Prostate Cancer Managed During the Prostate-Specific Antigen Era, 10.1200/jco.2003.01.075
  4. Yossepowitch Ofer, Eggener Scott E., Bianco Fernando J., Carver Brett S., Serio Angel, Scardino Peter T., Eastham James A., Radical Prostatectomy for Clinically Localized, High Risk Prostate Cancer: Critical Analysis of Risk Assessment Methods, 10.1016/j.juro.2007.03.105
  5. Zwergel Ulrike, Suttmann Henrik, Schroeder Thomas, Siemer Stefan, Wullich Bernd, Kamradt Joern, Lehmann Jan, Stoeckle Michael, Outcome of Prostate Cancer Patients with Initial PSA ≥ 20 ng/ml Undergoing Radical Prostatectomy, 10.1016/j.eururo.2007.03.056
  6. Gallina Andrea, Jeldres Claudio, Chun Felix K.-H., Shariat Shahrokh F., Briganti Alberto, Walz Jochen, Roehrborn Claus G., Saad Fred, Huland Hartwig, Graefen Markus, Montorsi Francesco, Karakiewicz Pierre I., Prediction of Pathological Stage is Inaccurate in Men with PSA Values above 20ng/mL, 10.1016/j.eururo.2006.12.010
  7. RANA A., KARAMANIS K., LUCAS M. G., CHISHOLM G. D., Identification of Metastatic Disease by T Category, Gleason Score and Serum PSA Level in Patients with Carcinoma of the Prostate, 10.1111/j.1464-410x.1992.tb15528.x
  8. Lorente J.A., Morote J., Raventos C., Encabo G., Valenzuela H., Clinical Efficacy of Bone Alkaline Phosphatase and Prostate Specific Antigen in the Diagnosis of Bone Metastasis in Prostate Cancer, 10.1016/s0022-5347(01)66263-3
  9. Inman Brant A., Davies Judson D., Rangel Laureano J., Bergstralh Eric J., Kwon Eugene D., Blute Michael L., Karnes R. Jeffrey, Leibovich Bradley C., Long-term outcomes of radical prostatectomy with multimodal adjuvant therapy in men with a preoperative serum prostate-specific antigen level ≥50 ng/mL, 10.1002/cncr.23767
  10. Spahn Martin, Joniau Steven, Gontero Paolo, Fieuws Steffen, Marchioro Giansilvio, Tombal Bertrand, Kneitz Burkhard, Hsu Chao-Yu, Van Der Eeckt Katie, Bader Pia, Frohneberg Detlef, Tizzani Alessandro, Van Poppel Hein, Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients, 10.1016/j.eururo.2010.03.001
  11. Steuber Thomas, Erbersdobler Andreas, Graefen Markus, Haese Alexander, Huland Hartwig, Karakiewicz Pierre I., Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy, 10.1002/cncr.21632
  12. Even-Sapir, J Nucl Med, 47, 287 (2006)
  13. Lecouvet Frédéric E., Geukens Daphné, Stainier Annabelle, Jamar François, Jamart Jacques, d'Othée Bertrand Janne, Therasse Patrick, Berg Bruno Vande, Tombal Bertrand, Magnetic Resonance Imaging of the Axial Skeleton for Detecting Bone Metastases in Patients With High-Risk Prostate Cancer: Diagnostic and Cost-Effectiveness and Comparison With Current Detection Strategies, 10.1200/jco.2006.09.2940
  14. Swanson Gregory, Thompson Ian, Basler Joseph, Crawford E. David, Metastatic Prostate Cancer—Does Treatment of the Primary Tumor Matter?, 10.1016/j.juro.2006.06.069
  15. Laverdière Jacques, Gomez JoséL., Cusan Leonelo, Raul Suburu Elbio, Diamond Pierre, Lemay Martin, Candas Bernard, Fortin André, Labrie Fernand, Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer, 10.1016/s0360-3016(96)00513-5
  16. Crook Juanita, Malone Shawn, Perry Gad, Bahadur Yasir, Robertson Susan, Abdolell Mohamed, Postradiotherapy prostate biopsies: what do they really mean? results for 498 patients, 10.1016/s0360-3016(00)00637-4
  17. Bolla Michel, Collette Laurence, Blank Léo, Warde Padraig, Dubois Jean Bernard, Mirimanoff René-Olivier, Storme Guy, Bernier Jacques, Kuten Abraham, Sternberg Cora, Mattelaer Johan, Torecilla José Lopez, Pfeffer J Rafael, Cutajar Carmel Lino, Zurlo Alfredo, Pierart Marianne, Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial, 10.1016/s0140-6736(02)09408-4
  18. Heidenreich Axel, Aus Gunnar, Bolla Michel, Joniau Steven, Matveev Vsevolod B., Schmid Hans Peter, Zattoni Filliberto, EAU Guidelines on Prostate Cancer, 10.1016/j.eururo.2007.09.002
Bibliographic reference Gontero, Paulo ; Spahn, Martin ; Tombal, Bertrand ; Bader, Pia ; Hsu, Chao-Yu ; et. al. Is there a prostate-specific antigen upper limit for radical prostatectomy?. In: BJU International, Vol. 108, no. 7, p. 1093-1100 (2011)
Permanent URL http://hdl.handle.net/2078.1/110076